Nami Imai
Impact in
- Hepatology top 5%
- Hepatocellular Carcinoma Treatment and Prognosis
- Oncology top 5%
- Inflammatory Biomarkers in Disease Prognosis
- Pancreatic and Hepatic Oncology Research
Papers in
- Oncology 8
- Inflammatory Biomarkers in Disease Prognosis 7
-
- Cancer, Lipids, and Metabolism 8
- Co-authors
- Akiyoshi Kinoshita (15 shared papers)Hiroshi Onoda (9 shared papers)Nao Fushiya (11 shared papers)Kazuhiko Koike (13 shared papers)Akira Iwaku (13 shared papers)Mutumi Oishi (6 shared papers)Hirokazu Nishino (8 shared papers)Hisao Tajiri (8 shared papers)
- Journals
- World Journal of Gastroenterology (2 papers)Oncology (2 papers)Clinical & Translational Oncology (1 paper)British Journal of Cancer (1 paper)Environmental Health and Preventive Medicine (1 paper)
- Partner nations
- Japan
In The Last Decade
Nami Imai
20 papers receiving 959 citations
Peers
Comparison fields: 5 of 89
- Hepatology 239
- Oncology 645
- Cancer Research 277
- Internal Medicine 57
- Otorhinolaryngology 36
Countries citing papers authored by Nami Imai
This map shows the geographic impact of Nami Imai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nami Imai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nami Imai more than expected).
Fields of papers citing papers by Nami Imai
This network shows the impact of papers produced by Nami Imai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nami Imai. The network helps show where Nami Imai may publish in the future.
Co-authors
The 25 scholars most cited alongside Nami Imai, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 21 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2014 | 364 | |
| 2 | 2012 | 246 | |
| 3 | 2013 | 92 | |
| 4 | 2012 | 55 | |
| 5 | 2013 | 50 | |
| 6 | C-Reactive Protein as a Prognostic Marker in Patients with Hepatocellular Carcinoma. | 2015 | 35 |
| 7 | 2018 | 30 | |
| 8 | 2008 | 17 | |
| 9 | 2008 | 14 | |
| 10 | 2007 | 14 | |
| 11 | 2014 | 13 | |
| 12 | 2012 | 7 | |
| 13 | 2017 | 6 | |
| 14 | 2017 | 6 | |
| 15 | 2015 | 6 | |
| 16 | 2018 | 6 | |
| 17 | 2016 | 5 | |
| 18 | 2021 | 3 | |
| 19 | [A Case of Advanced Gastric Cancer with Bladder Metastasis]. | 2018 | 1 |
| 20 | 2020 | 1 |
About Nami Imai
Nami Imai is a scholar working on Oncology, Cancer Research, Hepatology, Surgery and Pulmonary and Respiratory Medicine, having authored 21 papers that have together received 971 indexed citations. Recurring topics across this work include Cancer, Lipids, and Metabolism (8 papers), Hepatocellular Carcinoma Treatment and Prognosis (7 papers), Inflammatory Biomarkers in Disease Prognosis (7 papers), Liver Disease Diagnosis and Treatment (4 papers), Body Composition Measurement Techniques (2 papers), Pancreatitis Pathology and Treatment (2 papers), Exercise and Physiological Responses (2 papers) and Appendicitis Diagnosis and Management (2 papers). The work is most often cited by research in Hepatology (239 citations), Oncology (645 citations), Cancer Research (277 citations), Internal Medicine (57 citations) and Otorhinolaryngology (36 citations). Nami Imai has collaborated with scholars based in Japan. Frequent co-authors include Akiyoshi Kinoshita, Hiroshi Onoda, Nao Fushiya, Kazuhiko Koike, Akira Iwaku, Mutumi Oishi, Hirokazu Nishino, Hisao Tajiri, Ken Tanaka and Masato Matsushima. Their work appears in journals such as World Journal of Gastroenterology, Oncology, Clinical & Translational Oncology, British Journal of Cancer and Environmental Health and Preventive Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.